Hamilton Capital LLC Raises Stock Position in UnitedHealth Group Incorporated $UNH

Hamilton Capital LLC raised its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 19.0% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 733 shares of the healthcare conglomerate’s stock after purchasing an additional 117 shares during the quarter. Hamilton Capital LLC’s holdings in UnitedHealth Group were worth $384,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also bought and sold shares of the company. Bayforest Capital Ltd lifted its holdings in shares of UnitedHealth Group by 685.7% in the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after acquiring an additional 48 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd increased its holdings in UnitedHealth Group by 416.7% in the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock worth $32,000 after acquiring an additional 50 shares in the last quarter. Copia Wealth Management purchased a new stake in UnitedHealth Group in the 4th quarter worth approximately $42,000. IAG Wealth Partners LLC purchased a new stake in UnitedHealth Group during the 1st quarter valued at approximately $42,000. Finally, Investment Management Corp VA ADV bought a new stake in shares of UnitedHealth Group during the fourth quarter worth $44,000. 87.86% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several research firms recently weighed in on UNH. Wall Street Zen downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Saturday, May 24th. Robert W. Baird reaffirmed an “underperform” rating and set a $198.00 target price (down from $312.00) on shares of UnitedHealth Group in a research note on Thursday, July 31st. Bank of America upped their target price on UnitedHealth Group from $290.00 to $325.00 and gave the company a “neutral” rating in a report on Monday, August 18th. Barclays increased their price target on UnitedHealth Group from $337.00 to $352.00 and gave the company an “overweight” rating in a research report on Thursday. Finally, HSBC reiterated a “reduce” rating and issued a $270.00 price objective (down previously from $490.00) on shares of UnitedHealth Group in a report on Wednesday, May 21st. Sixteen analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $354.86.

UnitedHealth Group Stock Performance

UnitedHealth Group stock opened at $315.10 on Monday. The firm has a market capitalization of $285.38 billion, a P/E ratio of 13.65, a PEG ratio of 2.04 and a beta of 0.44. The stock has a fifty day moving average price of $288.78 and a 200 day moving average price of $372.56. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $630.73. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. During the same period last year, the business posted $6.80 EPS. The company’s revenue for the quarter was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be given a dividend of $2.21 per share. The ex-dividend date is Monday, September 15th. This represents a $8.84 annualized dividend and a dividend yield of 2.8%. UnitedHealth Group’s dividend payout ratio (DPR) is 38.30%.

Insider Activity

In other news, CEO Patrick Hugh Conway sold 589 shares of UnitedHealth Group stock in a transaction on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total transaction of $179,645.00. Following the transaction, the chief executive officer directly owned 10,398 shares in the company, valued at approximately $3,171,390. This trade represents a 5.36% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 0.28% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.